StockData
Ocugen, Inc. logo

Ocugen, Inc. (OCGN) stock

OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$0.74−0.02 (-2.31%)

Close on Nov 18, 2026Market cap $250.67MP/E –Yield –

Ocugen revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Ocugen's revenue for the twelve months ending Sep 30, 2025 was $5.37M, up 14.3% year over year. For fiscal 2025 it was $4.41M, up 8.8% from the year before. The highest annual figure on record is $6.04M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.41M+8.8%
FY2024Dec 31, 2024$4.06M-32.8%
FY2023Dec 31, 2023$6.04M+142.6%
FY2022Dec 31, 2022$2.49M–
FY2021Dec 31, 2021$0-100.0%
FY2020Dec 31, 2020$43.00K–
FY2019Dec 31, 2019$0–
FY2018Dec 31, 2018$0–
FY2017Dec 31, 2017$0–
FY2016Dec 31, 2016$0–
FY2015Dec 31, 2015$0–
FY2014Dec 31, 2014$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.49M+0.5%
Q1 FY2026Mar 31, 2026$1.53M+100.7%
Q3 FY2025Sep 30, 2025$1.75M+54.2%
Q2 FY2025Jun 30, 2025$1.37M+20.3%
Q1 FY2025Mar 31, 2025$1.48M+46.1%
Q4 FY2024Dec 31, 2024$764.00K-45.8%
Q3 FY2024Sep 30, 2024$1.14M-69.3%
Q2 FY2024Jun 30, 2024$1.14M+135.3%
Q1 FY2024Mar 31, 2024$1.01M+128.9%
Q4 FY2023Dec 31, 2023$1.41M+60.3%
Q3 FY2023Sep 30, 2023$3.70M+693.8%
Q2 FY2023Jun 30, 2023$485.00K-24.6%
Q1 FY2023Mar 31, 2023$443.00K-11.4%
Q4 FY2022Dec 31, 2022$879.00K–
Q3 FY2022Sep 30, 2022$466.00K–
Q2 FY2022Jun 30, 2022$643.00K–
Q1 FY2022Mar 31, 2022$500.00K–
Q4 FY2021Dec 31, 2021$0–
Q3 FY2021Sep 30, 2021$0-100.0%
Q2 FY2021Jun 30, 2021$0–
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$43.00K–
Q4 FY2019Dec 31, 2019$0–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0–
Q1 FY2019Mar 31, 2019$0–
Q4 FY2018Dec 31, 2018$0–
Q3 FY2018Sep 30, 2018$0–
Q2 FY2018Jun 30, 2018$0–
Q1 FY2018Mar 31, 2018$0–
Q4 FY2017Dec 31, 2017$0–
Q3 FY2017Sep 30, 2017$0–
Q2 FY2017Jun 30, 2017$0–
Q1 FY2017Mar 31, 2017$0–
Q4 FY2016Dec 31, 2016$0–
Q3 FY2016Sep 30, 2016$0–

More Ocugen figures

See a number that looks wrong?